Joachim Diebold
Joachim Diebold
Professor für Pathologie, Luzerner Kantonsspital
Verified email at - Homepage
Cited by
Cited by
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
D Lodygin, V Tarasov, A Epanchintsev, C Berking, T Knyazeva, H Körner, ...
Cell cycle 7 (16), 2591-2600, 2008
From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression
O Schmidt-Kittler, T Ragg, A Daskalakis, M Granzow, A Ahr, ...
Proceedings of the National Academy of Sciences 100 (13), 7737-7742, 2003
Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
J Mazieres, S Peters, B Lepage, AB Cortot, F Barlesi, M Beau-Faller, ...
Journal of clinical oncology 31 (16), 1997-2003, 2013
Functional epigenomics identifies genes frequently silenced in prostate cancer
D Lodygin, A Epanchintsev, A Menssen, J Diebold, H Hermeking
Cancer research 65 (10), 4218-4227, 2005
Inheritance of gene density–related higher order chromatin arrangements in normal and tumor cell nuclei
M Cremer, K Küpper, B Wagler, L Wizelman, J Hase, Y Weiland, L Kreja, ...
The Journal of cell biology 162 (5), 809-820, 2003
Apoptosis and immunohistochemical bcl‐2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significance
GB Baretton, J Diebold, G Christoforis, M Vogt, C Müller, K Dopfer, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1996
Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort
J Mazières, G Zalcman, L Crinò, P Biondani, F Barlesi, T Filleron, ...
Journal of clinical oncology 33 (9), 992-999, 2015
Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer
N Anand, S Murthy, G Amann, M Wernick, LA Porter, IH Cukier, C Collins, ...
Nature genetics 31 (3), 301-305, 2002
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
S Brand, F Beigel, T Olszak, K Zitzmann, ST Eichhorst, JM Otte, J Diebold, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 289 (5 …, 2005
CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation
S Brand, J Dambacher, F Beigel, T Olszak, J Diebold, JM Otte, B Göke, ...
Experimental cell research 310 (1), 117-130, 2005
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants
D Mayr, A Hirschmann, U Löhrs, J Diebold
Gynecologic oncology 103 (3), 883-887, 2006
The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
A Menssen, P Hydbring, K Kapelle, J Vervoorts, J Diebold, B Lüscher, ...
Proceedings of the National Academy of Sciences 109 (4), E187-E196, 2012
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast-and Gynecopathologists
Z Varga, J Diebold, C Dommann-Scherrer, H Frick, D Kaup, A Noske, ...
PloS one 7 (5), e37379, 2012
bcl-2 Expression, p53 Accumulation, and Apoptosis in Ovarian Carcinomas
J Diebold, G Baretton, M Felchner, W Meier, K Dopfer, M Schmidt, U Löhrs
American journal of clinical pathology 105 (3), 341-349, 1996
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate
J Engel, R Eckel, G Schubert-Fritschle, J Kerr, W Kuhn, J Diebold, ...
European Journal of Cancer 38 (18), 2435-2445, 2002
Targeting RET in patients with RET-rearranged lung cancers: results from the global, multicenter RET registry
O Gautschi, J Milia, T Filleron, J Wolf, DP Carbone, D Owen, R Camidge, ...
Journal of Clinical Oncology 35 (13), 1403, 2017
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J Mazieres, A Drilon, A Lusque, L Mhanna, AB Cortot, L Mezquita, ...
Annals of Oncology 30 (8), 1321-1328, 2019
Photodynamic therapy of vulvar intraepithelial neoplasia using 5‐aminolevulinic acid
P Hillemanns, M Untch, C Dannecker, R Baumgartner, H Stepp, J Diebold, ...
International journal of cancer 85 (5), 649-653, 2000
A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib
O Gautschi, C Pauli, K Strobel, A Hirschmann, G Printzen, S Aebi, ...
Journal of Thoracic Oncology 7 (10), e23-e24, 2012
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer
M Varella-Garcia, J Diebold, DA Eberhard, K Geenen, A Hirschmann, ...
Journal of clinical pathology 62 (11), 970-977, 2009
The system can't perform the operation now. Try again later.
Articles 1–20